2002, Number S1
<< Back Next >>
Arch Cardiol Mex 2002; 72 (S1)
Specific dilated cardiomyopathy. Chronic chagasic cardiomyopathy in the INCICH
Monteón-Padilla VM, Vargas-Alarcón G, Vallejo-Allende M, Reyes PA
Language: Spanish
References: 11
Page: 148-152
PDF size: 60.17 Kb.
ABSTRACT
Cardiomyopathies are a heterogenous group of heart ailments. Some of them are primary myocardial diseases and are classified as dilated, hypertrophic, restrictive and arrhitmogenic. Dilated cardiomyopathies (DCs) are the most common. Sometimes it is possible to identify an etiologic agent, in that case we talk about a specific dilated cardiomyopathy. Here in, we review one of these specific DCs, the so called Chronic Chagasic Cardiopathy (CCC) from the point of view of our personal experience at the Instituto Nacional de Cardiología “Ignacio Chávez”. Chagas’ disease is present in Mexico, therefore CCC is also present. We stimate that 5,000 people, suffer CCC with severe symptoms. In Mexico, Chagas’ disease occurs below the Tropic of Cancer and between 2,000-2,500 m above sea level, in this area there is a real risk for vectorial infection, mianly in rural villages. Clinical diagnosis should be supported by epidemiological and seroepidemiological confirmatory data. There is not appropriate therapy yet for this condition.
REFERENCES
Brandenburg RO, Chazov E, Cherina G, Martín V, Orinius E, Goodwin JF, et al: Report of the WHO/ISFC Task Force on definition and classification of cardiomyopathies. Circulation 1981; 64: 437A-438A.
OPS/OMS 1994: Las condiciones de salud en las Américas. Publicación Científica No 549.
Moreno RM, Sánchez PL, Muñoz JL, Monteón VM, Reyes PA: Cardiopatía chagásica en Tehuantepec. Informe preliminar. Arch Cardiol Mex 2001; 71: 43-9.
Velasco O, Valdespino R, Tapia B, Salvatierra C, Guzmán C, Magos A, et al: Seroepidemiología de la enfermedad de Chagas en México. Salud Publ Mex 1992; 34: 186-92.
Monteón-Padilla VM, Hernández N, Guzmán-Bracho C, Rosales-Encina JL, Reyes PA: American Trypanosomosis (Chagas’ Disease) and blood banking in México City: seroprevalence and its potential transfusional transmision risk. Arch Med Res 1999; 30: 393-8.
Monteón-Padilla VM, Negrete GC, Reyes PA: Chronic chagasic Cardiopathy with parasitemic state (Preliminary report). Arch Med Res 1996; 27: 335-7.
Monteón VM, Guzmán-Bracho C, Florián-Verdugo J, Ramos-Echeverría A, Velasco-Castrejón O, Reyes PA: Diagnóstico serológico de la enfermedad de Chagas: autosuficiencia y concordancia interlaboratorios. Salud Publ Mex 1995; 37: 232-5.
Monteón-Padilla VM, Reyes PA, Rosales-Encina JL: Detección de Tripanosoma cruzi en muestras experimentales por el método de reacción en cadena de la ADN polimerasa. Arch Inst Cardiol Mex 1994; 64: 135-43.
Kierszenbaum F: Chagas’ disease and the autoimmune hypothesis. Clin Microbiol Rev 1999; 12: 210-23.
Bocchi EA, Bellotti G, Uip D, Kalil J, Higuchi M de L, Fiorelli A, et al: Long term follow up after Heart transplantation in Chagas’ Disease. Transplant Proc 1993; 25: 1329-30.
Vallejo-Allende M, Montenegro P, Reyes PA: ¿Cuesta menos prevenir que tratar la cardiopatía chagásica Crónica? Costos directos mínimos en un hospital de Cardiología. En prensa.